| - GRCh37:
- ChrX:47060333
- GRCh38:
- ChrX:47200934
| UBA1 | R174Q | Infantile-onset X-linked spinal muscular atrophy, Infantile-onset X-linked spinal muscular atrophy, VEXAS syndrome, Inborn genetic diseases | Uncertain significance (May 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:47061002
- GRCh38:
- ChrX:47201603
| UBA1 | K268N | not provided, Infantile-onset X-linked spinal muscular atrophy, VEXAS syndrome
| Uncertain significance (May 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:47058446
- GRCh38:
- ChrX:47199047
| LOC126863253, UBA1 | | VEXAS syndrome | Pathogenic (Sep 30, 2021) | no assertion criteria provided |
| - GRCh37:
- ChrX:47058496
- GRCh38:
- ChrX:47199097
| LOC126863253, UBA1 | | Infantile-onset X-linked spinal muscular atrophy | Uncertain significance (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:47058450
- GRCh38:
- ChrX:47199051
| LOC126863253, UBA1 | M41L | not provided, VEXAS syndrome, Infantile-onset X-linked spinal muscular atrophy
| Conflicting interpretations of pathogenicity (Jan 3, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:47058451
- GRCh38:
- ChrX:47199052
| LOC126863253, UBA1 | M41T | UBA1-related condition, VEXAS syndrome, Infantile-onset X-linked spinal muscular atrophy, not provided | Conflicting interpretations of pathogenicity (Aug 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:47058450
- GRCh38:
- ChrX:47199051
| UBA1, LOC126863253 | M41V | Infantile-onset X-linked spinal muscular atrophy, UBA1-related condition, Inborn genetic diseases, not provided, VEXAS syndrome | Conflicting interpretations of pathogenicity (May 10, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:47065473
- GRCh38:
- ChrX:47206074
| UBA1 | L568V | Infantile-onset X-linked spinal muscular atrophy, VEXAS syndrome, not specified, Infantile-onset X-linked spinal muscular atrophy | Benign/Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |